H5N1 whole virus influenza vaccine (Daronrix) - GSK
Alternative Names: Daronrix; Pre-pandemic mock-up vaccine (Daronrix) - GSKLatest Information Update: 02 Aug 2023
At a glance
- Originator ID Biomedical Corporation
- Developer GSK
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Influenza A virus H5N1 subtype
Most Recent Events
- 21 Mar 2007 Registered for Influenza-A virus H5N1 subtype in European Union (IM)
- 31 Dec 2005 Preregistration for Influenza-A virus H5N1 subtype in European Union (IM)
- 24 Jan 2005 Preclinical trials in Influenza-A virus H5N1 subtype in Canada (IM)